{'fraction_non_alphanumeric': 0.026607538802660754, 'fraction_numerical': 0.0022172949002217295, 'mean_word_length': 5.191780821917808, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 2, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Anal cancer screening and Pap testing acceptability among HIV‐positive men who have sex with men populations

We read with interest the publication by Torodova et al. [1] which evaluated anal carcinoma screening in male and female HIV patients at an interdisciplinary HIV therapy centre. The study has a number of strengths including a large, representative clinical population of HIV-positive patients (predominantly men who have sex with men (MSM)).